Skip to content

Clinical trials

Completed Lymphoma, Large-Cell, Anaplastic trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Large-Cell, Anaplastic Status: Completed Country / region: United States Clear all

215 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200015
20018
200210
200313
200411
200512
200613
200717
200812
200912
20109
201112
20127
20138
20142
20152
20161
20171
20181
20191
20201
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed215

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)44
Fred Hutchinson Cancer Center16
Memorial Sloan Kettering Cancer Center13
Mayo Clinic9
Case Comprehensive Cancer Center8
Seagen Inc.8
National Institutes of Health Clinical Center (CC)7
City of Hope Medical Center6
Roswell Park Cancer Institute6
University of Nebraska6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Large-Cell, Anaplastic215
Lymphoma, Large B-Cell, Diffuse167
Lymphoma, Mantle-Cell154
Burkitt Lymphoma151
Lymphoma, Follicular151
Immunoblastic Lymphadenopathy149
Lymphoma, Non-Hodgkin146
Hodgkin Disease143
Lymphoma, B-Cell, Marginal Zone143
Leukemia, Lymphocytic, Chronic, B-Cell142

Trials

Showing 1 to 25 of 215. Each trial links to its page on Pharma Observatory.

115 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.